What You Need to Know

• A Philadelphia-area biotechnology company has agreed to a $44.9 million settlement to resolve allegations that it defrauded government health care programs.
• Ross Feller Casey represented the two whistleblowers who initiated the qui tam False Claims Act suit.
• Ross Feller Casey's Brian McCormick said collaboration between his firm and the federal government allowed for a more effective investigation.

A Philadelphia-area biotechnology company has agreed to a $44.9 million settlement to resolve allegations that it defrauded government health care programs by seeking reimbursements for services it outsourced to often-unlicensed technicians outside of the United States.

And it is good news for two whistleblowers who are set to split $8.3 million under the terms of the agreement and are represented by Ross Feller Casey’s Brian McCormick who worked with federal prosecutors to bring the False Claims Act action.

Want to continue reading?
Become an ALM Digital Reader for Free!

Benefits of a Digital Membership

• Free access to 1 article* every 30 days
• Access to the entire ALM network of websites
• Unlimited access to the ALM suite of newsletters
• Build custom alerts on any search topic of your choosing
• Search by a wide range of topics

Already have an account? https://news.google.com/__i/rss/rd/articles/CBMiemh0dHBzOi8vd3d3Lmxhdy5jb20vd...